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Abstract
Recombination activating gene (RAG)-deficient TCR (T Cell Receptor) Tg (transgenic) mice are routinely used as sources of
monoclonal T cells. We found that after the transfer of T cells from a RAG-2-deficient 5CC7 TCR Tg mice into allogeneic hosts
we recovered a population of T cells expressing diverse ab-TCRs. In fact, in the thymus and spleen of the 5CC7 RAG-2-
deficient donor mice, we detected rare T cells expressing non-Tg TCR chains. Similar observations were obtained using T
cells from two other TCR transgenic strains, namely RAG-2-deficient aHY and RAG-1-deficient OT-1 mice. The sequences of
the endogenous TCR transcripts suggested that gene recombination could occur, albeit quite inefficiently, in the RAG-
deficient mice we used. In agreement, we evidenced rare TCR Va and Vb-chain transcripts in non-Tg RAG-2-deficient mice.
Since in these non-Tg RAG-deficient mice no mature T cells could ever be found, our findings suggested a role for the TCR
Tg in rescuing rare recombined endogenous chains. Robust T-cell activation by the allogeneic environment favored the
selection and expansion of the rare cells expressing endogenous TCRs. Potential mechanisms involved in the recombination
of the endogenous TCR chains in the different strains of RAG-deficient mice used, and in particular the possibility of RAG-1
hypomorphism due to an incomplete knocking out procedure, are discussed. Our findings have important experimental
implications for studies using TCR-Tg RAG-deficient cells as monoclonal T cell populations.
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Introduction
The development of T cell receptor (TCR) transgenic (Tg) mice
offered a promising tool to circumvent the low frequency of T-cells
specific for a given antigen [1,2]. Indeed, these mice permitted
valuable studies on T cell development and immune responses
[1,2,3]. However, endogenous TCR expression was still observed
[4], reflecting mainly the incomplete allelic exclusion of the TCRa
chain. To obtain pure monoclonal T cell populations, TCR Tg
mice were crossed with RAG-1 or RAG-2-deficient mice [5,6,7].
The lymphocyte-specific recombination genes RAG-1 and RAG-2
encode RAG-1 and RAG-2 proteins that together form a complex
responsible for recognizing and cutting V, D and J segments
thereby initiating V(D)J rearrangement [8]. Since it was
understood that recombination requires both RAG genes [9], the
functional impairment of only one of the two genes was believed to
abolish any endogenous TCR or B cell receptor (BCR) expression.
In agreement it was found that either RAG-1 or RAG-2-knocked
out mice have no detectable T and B cells [5,6,7] and when
crossed into a TCR Tg background, they appeared to contain a
single homogeneous monoclonal population of mature T-cells
expressing the TCR-Tg and no B cells [10].
We exploited this property to study the fate of monoclonal CD4
naı ¨ve T-cells in different MHC environments. We found that upon
transfer into allogeneic RAG
0/0 cc
0/0 hosts, T cells from TCR Tg
RAG-2-deficient mice, namely the 5CC7 strain, proliferate.
However, we unexpectedly found that with time most of the
donor T cells recovered from the allogeneic hosts did not express
the TCR Tg, but expressed other endogenous ab TCRs. Based on
these observations, we were able to detect rare T cells expressing
non-Tg TCRs in the thymus and periphery of the donor mice in
spite of their RAG-deficiency. Sequence analysis of the expressed
endogenous TCRs strongly suggested that RAG-dependent TCR
recombination occured in the RAG-knocked out (KO) strains
used. Similar observations were obtained using aHY TCR Tg
RAG-2-and OT-1 TCR Tg RAG-1 deficient strains. If in the case
of the RAG-2-deficient mice it is conceivable that RAG-1 alone
could perform VDJ recombination, this hypothesis is very unlikely
for RAG-1-deficient mice. However, two RAG-1 knockout alleles
have been generated and the RAG-1 KO strain we have analyzed
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10238here has the potential to be a hypomorphic allele due to the
remaining expression of the essential catalytic RAG-1 core.
Results
Expression of endogenous TCR-chains by T cells from
TCR Tg RAG-deficient mice transferred into allogeneic
hosts
To compare the fate of monoclonal TCR Tg 5CC7 T cells in
different MHC environments, we transferred CFSE-labeled T-
cells from H-2
a 5CC7 TCR Tg RAG-2-deficient [6] donors into
either H-2
a (syngeneic) or H-2
b (allogeneic) RAG-2
0/0cc
0/0 hosts.
Deprived of T, B and NK cells, these hosts are unable to reject
allogeneic donor cells. We studied CFSE-dilution and expression
of the TCR Va11 and Vb3 Tg chains by the donor T-cells. Five
weeks after transfer, the majority of the T-cells divided in both
syngeneic and allogeneic hosts (Figure 1a). Unexpectedly, while in
the syngeneic hosts 80% of the recovered T-cells were CD4
+ and
Va11
+, in the allogeneic hosts 40% were CD8
+ T-cells and Va11
2
(Figure 1a). The study of the co-expression of Va11 and Vb3 TCR
Tg chains confirmed that in the allogeneic hosts most of the CD4
+
T-cells were Va11
+ Vb3
+ (Figure 1b), but only a minority (0.4%)
of the CD8
+ T-cells expressed the TCR ab Tg chains. Moreover,
at 28 weeks after transfer, while in the syngeneic hosts virtually all
donor T-cells remained Va11
+Vb3
+, almost none of the CD4
+
and CD8
+ T-cells recovered in the allogeneic hosts expressed the
TCR Tg chains (Figure 1b). Noteworthy, all the CD3
+ TCR Tg
T-cells recovered from allogeneic hosts expressed a TCRb chain
(Figure 1c) and were TCR cd
2 (data not shown), confirming that
these Va11
2Vb3
2 cells expressed a TCR and belonged to the ab
T cell lineage.
In order to confirm the expression of endogenous TCRs by the
donor RAG-2-deficient T-cells in the allogeneic hosts, we analyzed
their TCRa and b chain usage by Immunoscope [11]. We found
that CD4 and CD8 T-cell populations expressed multiple non-Tg
a and b TCR-chain transcripts with significant Complementaring
Determining Region (CDR)3 length complexity (Figure 1d).
Interestingly, we were unable to detect Va11- and Vb3-peaks
other than those corresponding to the Tg-encoded transcripts.
This observation suggests the presence of dual TCR expressing T-
cells where the abundant Tg chain message may have masked the
detection of the endogenous rearranged Va11- and Vb3-
transcripts. The finding of Vb3-Cb transcripts expressing Jb gene
segments different from the Jb Tg confirmed this hypothesis (not
shown).
It is important to note that we confirmed the RAG-deficiency in
all donor and host mice both by Flow Cytometry and by a 35–40
cycle PCR (using specific RAG-1 and RAG-2 primers able to
distinct between WT and KO allele) (see M&M). We should add
that by using the same PCR and Immunoscope conditions, we
were unable to detect any TCRb mRNA transcripts among the
spleen cells of TCRb gene enhancer
0/0 mice [12] (not shown).
Taken together, these findings indicate that transfer of TCR-Tg
T cells from 5CC7 RAG-2-deficient donors into allogeneic hosts,
resulted in the ‘‘selection’’ of donor T cells expressing diverse
endogenous TCRs.
Endogenous TCR expression in the thymus and periphery
of TCR Tg RAG-deficient mice
Endogenous TCR chain expression by the T-cells recovered
from the allogeneic hosts could result from the expansion of pre-
existing donor T cells or be ‘‘de novo’’ induced upon T cell
transfer. We investigated whether rare T-cells expressing endog-
enous TCRs pre-existed in the 5CC7 RAG-2
0/0 donors.
Surprisingly and in spite of the RAG-2-deficiency, we detected
expression of non-Tg Va and Vb TCRs in the thymus and
periphery of the donor mice (Figure 2). On average from 100610
6
thymocytes analyzed, 0.5–1% of the double positive (DP) CD3
+
thymocytes (about 10000 DP cells) and about 0.1% of the single
positive (SP) T-cells (30000 SPCD4 and 1500 SPCD8) did not
express one or both TCR Tg chains (Figure 2a upper panels).
These observations were confirmed by Immunoscope, which
revealed the presence of rare non-Tg TCRa chain transcripts
among the thymus cells (Figure 2a lower panels). Peripheral CD8
+
T-cells from 5CC7 RAG-2
0/0 were more prone to express
endogenous TCRs than the CD4
+ T-cells (Figure 2b upper
panels). The expression of endogenous TCRs by the CD8 T cells
varied however, from 0.1% to 15% in different individual mice
(not shown). We also detected endogenous Va2 and Va10
transcripts in the spleen of the 5CC7 RAG-2
0/0 donor mice
(Figure 2b lower panels). These results strongly suggest the
preexistence of endogenous TCR bearing T cells in the 5CC7
RAG-2
0/0 mice, among which some may have been selected and
expanded in the allogeneic environment.
Based on this observations, we estimated the number of cells
expressing Tg and/or endogenous TCR chains present among the
transferred T-cells and evaluated their expansion after transfer
into allogeneic and syngeneic hosts. In allogeneic hosts, the
number of CD4
+ and CD8
+ T-cells expressing endogenous TCRs
increased dramatically ($1000 fold) and represented the majority
of the T-cells recovered 28 weeks after transfer, while the number
of TCR Tg expressing cells decreased with time. In contrast, in
syngeneic hosts, T-cells expressing Tg TCRs represented the
majority of the recovered T-cells (Figure 2c). These results strongly
indicate that the allogeneic environment favors the selection and
expansion of pre-existing endogenous TCR bearing T-cells.
Endogenous TCR diversity evokes RAG-dependent
recombination
Endogenous TCR expression in the 5CC7 RAG-2-deficient
mice could be mediated either by RAG-dependent recombination
[13], gene conversion [14] or gene replacement [15] mechanisms
involved in the generation of BCR and TCR diversity. To
discriminate between these possibilities, we sequenced some of the
TCRa and TCRb-chains used by T-cells recovered from the
allogeneic hosts. The sequences of the endogenous Va10 and
Vb8.1 TCR chains evidenced the usage of diverse Ja,D b and Jb
segments (Table 1). The number of genes involved argues against a
gene replacement mechanism, that could only occur if different Tg
copies were inserted in proximity to both the TCR-a and TCR-b
loci, an unlikely event. The perfect alignment between the V
sequences and the corresponding germ line sequences are
inconsistent with the insertion of V sequence fragments, a
hallmark of gene conversion. The sequences also showed
considerable CDR3 length diversity using different D- and J-gene
segments and containing motifs reminiscent of N/P additions [16].
Overall our findings suggest that RAG-dependent endogenous
TCR recombination occurs in T-cells from 5CC7 donor mice
despite their RAG-2-deficiency.
Endogenous TCR recombination in donor T cells from
other TCR Tg RAG-deficient T cells upon transfer into
allogeneic hosts
We next asked whether endogenous TCR recombination could
also occur in other TCR Tg RAG-deficient strains. We detected
rare non-Tg endogenous TCR chain transcripts after transfer of
RAG-2-deficient [6] aHY (Figure 3a, left panel) and RAG-1-
TCR Expression in RAG0/0 Mice
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allogeneic RAG-2
0/0cc
0/0H-2
a hosts. These results demonstrate
that the RAG-1- or RAG-2-deficient mice we have analyzed and
which are currently in use are still able to perform V(D)J TCR
recombination and that this process is independent of the
specificity and site of insertion of the TCR Tg.
Role of the TCR Tg in endogenous TCR expression
The absence of T cells in RAG-knocked out mice has been
largely reported leading to the assumption that the deficiency for
one RAG protein leads to the complete abolishment of TCR
recombination. In the light of our present results, we decided to
analyze TCR-encoding mRNAs in the spleen of RAG-2-deficient
mice, even though there was no evidence of any T cell
development in these mice. Using this approach, we were able
to evidence some rare TCR Va- and Vb-chain transcripts in the
spleen cells of RAG-2
0/0 mice (Figure 3b), probably reflecting
recombination that may have occurred in non-T, non-B cells, as
reported for NK cells [17]. TCR expression requires, however,
productive recombination in the two TCR chain loci. Thus, in the
absence of one RAG protein, the probability that such rare
recombination events might occur in the two TCR loci and in the
same cell must be too low to allow any T cell development.
However, in the presence of TCR Tg the rare recombined single
TCR chains (that can be detected in non-Tg RAG-deficient mice)
could readily associate with one of the Tg chains allowing the
protein to reach the cell surface and give rise to new receptor
specificities. If this was the case we would expect some 5CC7 T
cells to express ‘‘dual’’ TCRs. By flow cytometry, we confirmed
the existence of ‘‘dual’’ TCR-expressing T cells in 5CC7 RAG-2
0/0
mice (Figure 3c). About 0.04% of CD4
+Va11
+ and 0.07% of the
CD8
+Va11
+ LN 5CC7 T cells expressed the non-Tg Va2 chain
and 0.21% of CD4
+Vb3
+ and 0.33% of the CD8
+Vb3
+ LN 5CC7
T cells expressed non-Tg TCRb chains including Vb5.1, 5.2, Vb6
or Vb8.1, 8.2, 8.3 (Figure 3c). We concluded that TCR Tgs play a
critical role in resuing rare recombination events occurring in single
RAG mice and allowing surface expression of endogenous TCR
chains by T cells.
Discussion
In the present report, we clearly show that endogenous TCR
recombination occurs, albeit quite inefficiently, in RAG-2 (or RAG-
1) deficient TCR Tg mice. While this observation was first made on
5CC7 TCR Tg RAG-2-deficientmice,itis important tostate thatT
cell populations from two others TCR Tg RAG-deficient strains,
the aHY TCR Tg RAG-2-deficient mice, Tg for an H-2D
b-
restricted TCR, and the OT-1 TCR Tg RAG-1-deficient mice, Tg
Figure 1. Emergence of non Tg TCR expressing T-cells after transfer into allogeneic hosts. One million CFSE-labeled LN T-cells from 5CC7
RAG-2-deficient mice were injected into syngeneic H-2
a or allogeneic H-2
b RAG-2
0/0cc
0/0 hosts. Five (a,b) and 28 (b,c and d) weeks later, mice were
sacrificed and spleen cells were analyzed by Flow Cytometry or Immunoscope. (a) Dot plots show CFSE dilution and Va11 TCR Tg chain expression by
gated CD3
+CD4
+ or CD3
+CD8
+ 5 weeks after transfer. (b) Dot plots show expression of Va11 and Vb3 TCR Tg chains by gated CD3
+CD4
+ or CD3
+CD8
+
at 5 and 28 weeks after transfer; (c) Dot plots show that 28 weeks after transfer into allogeneic hosts both CD3
+CD4
+ and CD3
+CD8
+ Vb3
2 T-cells
were panb
+, i.e. they expressed a ab TCR. Each dot plot is representative of 3 to 6 different mice (d) Twenty-eight weeks after transfer, mRNA was
extracted from CD4 or CD8 donor T-cells recovered from pooled allogeneic hosts. mRNA were retro-transcribed and amplified using several Va (top
panels) and Vb (bottom panels) specific primers. CDR3 length profiles obtained by Immunoscope are shown, with CDR3 size on x-axis (peaks are
separated by 1 amino acid), and arbitrary scale of fluorescence on y-axis (proportional to the RT-PCR product amount). The bold framed profiles
correspond to the Va11 or Vb3 Tg transcripts.
doi:10.1371/journal.pone.0010238.g001
TCR Expression in RAG0/0 Mice
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b-restricted TCR, also expressed endogenous TCRs
after transfer into allogeneic RAG-2
0/0cc
0/0H-2
a. This indicates
that endogenous TCR recombination in T cells from TCR Tg
RAG-deficient mice is not restricted to a particular TCR Tg strain.
The nature of the TCR sequences obtained strongly support RAG-
like activity. Therefore our results suggest that in some of the
currently available TCR Tg RAG-deficient mice a single RAG
protein could induce VDJ recombination. Although it is acceptable
that RAG-1 alone could perform VDJ recombination since it has
both specific DNA binding domains and catalytic sites for DNA
cleavage (in agreement, we revealed the presence of rare isolated
mRNA transcripts showing TCR chain rearrangements in the
spleen cells of a non-Tg RAG-2 deficient mouse), this hypothesis is
very unlikely for RAG-2 since it lacks both DNA binding activity
and catalytic activity. It is possible that the RAG gene manipulations
used to produce the currently available RAG-1-deficient mice could
havelead to hypomorphicforms resultinginresidualrecombination
activity. This may occurs in the RAG-1 deficient mice used here,
due to a Neo-gene insertion at the position aa330 [7] that could
allow residual recombinase activity of the RAG-1 protein. Thus, the
present report challenges the traditional view that both RAG-1 and
RAG-2 proteins are strictly required to ensure V(D)J recombina-
tion, and indicate that RAG-1 alone may be sufficient to induce,
although at very low level, some TCR recombination. In these
conditions, one can not exclude that the widely accepted
monoclonality of RAG-deficient TCR Tg T cells would be due to
the suppression of both RAG loci, by cis or trans effects, resulting
from the insertion of the neo gene, as reported for other targeted
mutations [18]. Alternatively, other recombination proteins than
RAG may be involved (it is difficult to formally disprove a non
RAG-dependent mechanism as it would require creating a double
KO mice either by knocking out both genes in ES cells or by
crossing RAG-1 and RAG-2 KO mice, a highly improbable event
due to the physical linkage of the two loci).
While we clearly showed that rare endogenous TCRs could be
generated in RAG-1 and RAG-2-deficient TCR Tg mice, there is
no evidence for any B or T cell development in the non-Tg RAG-
1
0/0 or RAG-2
0/0 mice used in the present study, even though we
detected very rare TCR rearrangement in the spleen of non-Tg
RAG-2-deficient mice (Figure 3b). Therefore one must invoke a
specific role for the TCR Tg in the development of those T cells
where endogenous recombination occurs. Considering that the
endogenous TCR recombinations observed in non-Tg single
RAG-deficient mice are extremely rare, the probability that a
productive rearrangements occur in both a and b TCR loci and in
the same cell is likely too low to result in receptor expression. Most
likely, in the presence of the TCR Tg, the rare recombined
endogenous single TCR chains present could readily associate
with one of the TCR Tg chains allowing the protein to reach the
cell surface and give rise to new receptor specificities. Support for
this hypothesis was gathered from the observation that 5CC7 T
cells express ‘‘dual’’ TCRs. This was demonstrated both by
flowcytometry (Figure 3c) and by Immunoscope analysis where the
dominant peak profiles obtained for the transcripts of the Va11-
and Vb3-Tg chains suggested that the 5CC7 Tg was transcribed
in the majority of T cells (Figure 1d). We concluded that the
allogeneic transfer provided a selective environment favoring the
expansion of rare T cells expressing endogenous TCRs present in
the original T cell inoculums. The kinetics of expansion of
endogenous bearing T cells in allogeneic hosts strongly supported
Figure 2. Pre-existence of endogenous TCR expression in the thymus and peripheral lymphoid tissues of 5CC7 RAG-2
0/0 mice. (a–b)
Thymus and peripheral cells from 5CC7 RAG-2
0/0 mice were analyzed for the presence of non-Tg TCR expression both by Flow Cytometry and
Immunoscope analyses. (a) Top dot plots show the expression of the Va11 and Vb3 TCR Tg chains by CD3
lo/hiDN (CD4
2CD8
2), DP (CD4
+CD8
+),
SPCD4
+ and SPCD8
+ thymocytes. Lower panels show CDR3 length profiles for the Va11 Tg and other non-Tg Va transcripts present in retro-
transcribed and amplified mRNA from total thymocytes using several Va specific primers. (b) Top dot plots show the expression of the Va11 and Vb3
TCR Tg chains by CD3
+CD4
+ or CD3
+CD8
+ spleen T-cells. Bottom panels show CDR3 length profiles for the Va11 Tg and other non-Tg Va transcripts
present in retro-transcribed and amplified mRNA from total spleen cells using several Va specific primers. (c) T-cells from 5CC7 RAG-deficient donors
were transferred into allogeneic or syngeneic hosts. Panels show the numbers of endogenous (filled line) and Tg (dotted line) TCR expressing CD4
+
(circles) or CD8
+ (squares) T-cells present in the inoculum and 5 and 28 weeks after injection in allogeneic (upper graph) and syngeneic (lower graph)
hosts.
doi:10.1371/journal.pone.0010238.g002
TCR Expression in RAG0/0 Mice
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regulation of the TCR Tg resulting in cells expressing mainly
endogenous TCRs. Using dual-TCR Tg mice, it was shown that
chronic activation induces similarly the selection of cells expressing
preferentially only ‘‘one’’ of the several possible TCRs [19].
Our current findings have important experimental implications.
TCR Tg mice have been crossed with RAG-1 or RAG-2-KO mice
to obtainsingle homogeneous monoclonalpopulations of mature T-
cells. We now show that this is not always the case. Several
hypotheses can be proposed to explain why we happened upon our
unexpected observations while copious other studies using TCR Tg
RAG-deficientmicedid not. First, rare endogenous rearrangements
may occur more or less efficiently, depending on the TCR Tg and
the selective advantage it confers at the DN and DP thymocyte
stages and its survival adequacy in the peripheral environments.
Second, the detection of T-cells bearing endogenous TCR in RAG-
deficient Tg mice needs strong activation and selection either by
allogeneic stimuli, as in the present study, or autoimmune reactivity
[20] that do not often occur in classical protocols using specific
immunization. Moreover, the robust T-cell activation in the
allogeneic environment may have induced RAG gene re-expression
by the donor T-cells [21]. By transferring sorted GFP
neg peripheral
T-cellsfromTgNG-BACmiceexpressing GFPunderthecontrolof
the RAG-2 regulatory sequences [22] into allogeneic hosts, we
found that 6 weeks after transfer about 2–3% of the donor cells
become GFP
+ (Figure S1). RAG re-expression may have allowed
new TCR chain recombination and editing [23], generating new
chains that could readily associate with the available chain to
promote further diversity. The immune system seems to use all
possible means to avoid monoclonality (‘‘horror monoclonicus’’)
Table 1. Va/Ja and Vb/Db/Jb sequences of the TCR transcripts expressed by T cells recovered from allogeneic hosts.
time Va N/P n Ja
d0
Thymus
Va11 TGT GCT GCT GAG G CT TCC AAT ACC AAC AAA GTC GTC TTT GGA ACA GGG ACC Ja34*02
d0 Spleen Va11 TGT GCT GCT GAG G CT TCC AAT ACC AAC AAA GTC GTC TTT GGA ACA GGG ACC Ja34*02
28 wks
Spleen
(CD4
+)
Va10 TGT GCT ATG GA A CGG ATG GGC TAC AAA CTT ACC TTC GGG ACA GGA ACA Ja09
Va10 TGT GCT GCA AGC C CT TCT GGC AGC TGG CAA CTC ATC TTT GGA TCT GGA ACC Ja22
Va10 TGT GCT ATG GA CC T TT A T AAC ACC AAT ACA GGC AAA TTA ACC TTT GGG ATG GGG ACC Ja27
Va10 TGT GCT ATA GAT C GA GAC ACA AAT GCT TAC AAA GTC ATC TTT GGA AAA GGG ACA Ja30
Va10 TGT GCT ATA GA CC T CA A C AAT AAC AGA ATC TTC TTT GGT GAT GGG ACG Ja31
Va10 TGT GCT ATG TCT GGA GGA AGC AAT GCA AAG CTA ACC TTC GGG AAA GGC ACT Ja42
Va10 TGT GCT ATA G GT AAT AAC AAC AAT GCC CCA CGA TTT GGA GCG GGA ACC Ja43
Va10 TGT GCT T TT ACT GGC AGT GGT GGA AAA CTC ACT TTG GGG GCT GGA ACA Ja44
Va10 TGT GCT GTG GCC CC C ACG GGT TAC CAG AAC TTC TAT TTT GGG AAA GGA ACA Ja49
Va10 TGT GCT ATA GA AC CT GGA GCT AAC ACT GGA AAG CTC ACG TTT GGA CAC GGC ACC Ja52
28 wks
Spleen
(CD8
+)
Va10 TGT GCT AT CT C C ATG GGC TAC AAA CTT ACC TTC GGG ACA GGA ACA Ja09
Va10 TGT GCT ATA GAT C A G AAT TAT AAC CAG GGG AAG CTT ATC TTT GGA CAG GGA ACC Ja22
Va10 TGT GCT ATG GA G AAT TAT AAC CAG GGG AAG CTT ATC TTT GGA CAG GGA ACC Ja23
Va10 TGT GCT ATA GAT TCC AAT ACC GAC AAA GTC GTC TTT GGA ACA GGG ACC Ja34
Va10 TGT GCT ATG GA A CGG G AT ACA GGA GGT GCA GAT AGA CTC ACC TTT GGG AAA GGA ACT Ja45
Va10 TGT GC C CCA GGG G AC TAT GCA AAC AAG ATG ATC TTT GGC TTG GGA ACC Ja47
Va10 TGT GCT A CC CA A TCC TCC TCC TTC AGC AAG CTG GTG TTT GGG CAG GGG ACA Ja50
Va10 TGT GCT ATG GA A CGG TCC GGC ACT GGG TCT AAG CTG TCA TTT GGG AAG GGG GCA Ja58
time Vb N/P n Db N/P n Jb
d0 Spleen Vb3 TGT GCC AGC AG TC T GA AC A AT G CA AAC TCC GAC TAC ACC TTC GGC TCA GGG Jb1–2
28 wks
Spleen
(CD4
+)
Vb8.1 TGT GCC AGC AGT GAT G C GA A T TCT GGA AAT ACG CTC TAT TTT GGA GAA GGA Jb1–3
Vb8.1 TGT GCC AGC AGT GA CA GG GAC CAG GCT CCG CTT TTT GGA GAG GGG Jb1–5
Vb8.1 TGT GCC AGC AGT GAT AGG CAA AAT C CA AAC ACC GGG CAG CTC TAC TTT GGT GAA GGC Jb2–2
Vb8.1 TGT GCC AGC A C C AGG ACC GGG CAG CTC TAC TTT GGT GAA GGC Jb2–2
Vb8.1 TGT GCC AGC A TC GGA CTG GGG
GGG C
TT GAA CAG TAC TTC GGT CCC GGC Jb2–7
Vb8.1 TGT GCC AGC AGT G GG AGG G AT GAA CAG TAC TTC GGT CCC GGC Jb2–7
Vb8.1 TGT GCC AGC AGT GAT G T T GGG GGG GC G CTC CAT GAA CAG TAC TTC GGT CCC GGC Jb2–7
The PCR products derived from the Immunoscope studies performed at different times after transfer were sequenced using Va and Ca, and Vb and Cb specific primers.
doi:10.1371/journal.pone.0010238.t001
TCR Expression in RAG0/0 Mice
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have important implications as they allow modifications of the
peripheral T cell repertoires with the arising of new specificities that
can be selected and expanded by environmental antigens. Our
findings illustrate that, in adoptive T cell transfer experiments using
‘‘monoclonal’’ T cells from RAG-deficient TCR Tg donors,
monitoring the expression of the Tg TCR chains is an absolute
requirement for accurate interpretation of the results particularly
when these cells are transferred into ‘‘hostile’’ non-MHC compat-
ible environments. They indicate that TCR Tg mice in triple
TCRa,T C R d and TCRb KO mice may be ideal source of truly
monoclonal T cells, as they would also ensure the absence of trans-
lineage TCR expression [25].
Materials and Methods
Ethics Statement
Mice were cared for in accordance with Pasteur Institute
guidelines in compliance with European animal welfare regula-
tions, and all animal studies were approved by the Pasteur Institute
Safety Committee in accordance with French and European
guidelines.
Mouse strains
The 5CC7 mice used in this study are Tg for the rearranged
Va11 and Vb3 TCR chains specific for the COOH-terminal
epitope of pigeon cytochrome c (PCC 88–104) in the context of I-
E
k. The 5CC7 Tg mice were made homozygous for RAG-2
0/0
and the TCR Tg in a B10.A (H-2
a) genetic background. This
strain, referred to as B10.A/SgSnAi TCR–Cyt 5CC7-1 RAG-2
0/0,
can be purchased from the NIAID/Taconic Farms, Inc.
Exchange. The H-2
b OT-1 RAG-1
0/0 mice Tg for an anti-OVA
H-2K
b-restricted Va2
+Vb5
+ TCR [26] and the H-2
b aHY RAG-
2
0/0 mice Tg for an anti-HY H-2D
b-restricted VaT3.70
+Vb8.2
+
TCR were provided by the CDTA, CNRS, Orle ´ans, France.
RAG-2
0/0cc
0/0H-2
b and RAG-2
0/0cc
0/0H-2
a mice were kindly
provided by J. Di Santo, Institut Pasteur, France and B.
Figure 3. Role of the TCR Tg in endogenous TCR expression. (a) Endogenous TCR rearrangements in donor T cells from OT-1 TCR Tg RAG-1- and
aHY TCR Tg RAG-2-deficient mice after transfer into allogeneic hosts. One million LN T-cellsfrom OT-1 RAG-1-deficient or aHYRAG-2-deficient mice were
transferred into allogeneic RAG-2
0/0 cc
0/0 H2
a hosts. At 9 (OT-1) and 30 (aHY) weeks after transfer, mice were sacrificed. Total RNA was extracted from
spleen cells of each hosts and Immunoscope analyses were performed for Va chains of aHY donor T cell TCRs (left panel) and Vb chains of OT-1 donor T
cell TCRs (right panel). (b) Total mRNA was extracted from the spleen of a RAG-2
0/0 mouse, retro-transcribed, and amplified using several Va (left panel)
and Vb (right panel) specific primers. CDR3 length profiles are shown. (c) Shows co-expression of Va11 and Vb3 TCR Tg chains with the non-Tg Va2o r
Vb5.1.2, 6 and 8.1.2.3 TCR chains analyzed by flow cytometry on CD3
+CD4
+ or CD3
+CD8
+ LN T-cells from 5CC7 TCR Tg RAG-2
0/0 mice.
doi:10.1371/journal.pone.0010238.g003
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encoding GFP under the control of RAG-2 regulatory elements
[22] were a gift from Dr. F. Huetz.
Genotyping of RAG-deficient strains were performed on tail
DNA using a 35–40 cycle PCR. In each case, 3 primers were used
enabling to detect both WT and KO allele: for RAG-1 KO mice:
fwd59CAATGTGCAGCTCAGCAAGAAACT39–rvs59TTCCA-
GACTCACTTCCTCATTGCA39–neofwd59GCATCGCCTTC-
TATCGCCTTCTTGACG39 (WT band =421 pb; KO band =
600 pb); for RAG-2 KO mice: fwd59GGGAGGACACTCACT-
TGCCAGTA39-rvs59AGTCAGGAGTCTCCATCTCACTGA39-
neofwd59CGGCCGGAGAACCTGCGTGCAA39 (WT band =
263 pb; KO band =350 pb).
Adoptive transfers and cell phenotype analysis
10
6 carboxyfluorescein succimyl esterate (CFSE)-labeled 5CC7
LN T-cells were injected i.v. into syngeneic RAG-2
0/0cc
0/0H-2
a
and allogeneic RAG-2
0/0cc
0/0H-2
b hosts. For CFSE labeling, cells
at 10
7/ml in PBS were incubated with CFSE (Molecular Probes)
at a final concentration of 5 mM for 12 min at RT and washed
twice in RPMI 1640 containing L-alanyl-L-glutamine dipeptide
and 10% FCS. In other experiments, H-2
b OT-1RAG-1
0/0 TCR
Tg or H-2
baHYRAG-2
0/0 TCR Tg LN T-cells were injected i.v. into
syngeneic RAG-2
0/0cc
0/0H-2
b or allogeneic RAG-2
0/0cc
0/0H-2
a
hosts. At different times after transfer, mice were sacrificed and
spleen collected. After a blocking step with rat anti-CD16/32
mAbs (2.4G2), cells were stained using anti-CD3e (145-2C11),
anti-CD4 (RM4-5), anti-CD8a (53–6.7), anti-Va11(RR8-1), anti-
panb (H57-597) and anti-Vb3 (KJ25) mAbs from BD Pharmingen
coupled with the appropriate FITC, PE, PerCP, APC, PECy7
dyes. Anti-Va2, anti-Vb5.1.2, anti-Vb6, Vb8.2 and anti-
Vb8.1.2.3 mAbs were also from BD Pharmingen. Dead cells and
doublets were excluded. Ig control Abs are used for negative
controls as well as stainings of non CD4 CD8 size comparable
cells. All acquisitions and data analysis were performed with a
FACScalibur or a FACSCanto (Becton Dickinson, San Jose, CA
USA) interfaced to the Macintosh CellQuest or FlowJo software.
CDR3 length analyses
Total RNA was extracted from 2–10.10
6 thymus or spleen cells
using TRIZOL according to the manufacturer procedure
(Invitrogen). In some cases, total RNA was extracted from either
CD4 or CD8 T-cells enriched by positive magnetic sorting using
an AutoMACS (Milteny Biotec). cDNA was synthesized for
50 min at 42uC using superscript reverse-transcriptase (Invitrogen)
in the presence of an inhibitor of RNAse (RNAsin, Promega).
Protocols for TCR AV-AC (Va-Ca) and BV-BC (Vb-Cb) CDR3
spectratyping have been described [11]. AC, AV, BC and BV
primers were as described [11], except BV8.3 (TGCTG-
GCAACCTTCAAATAGGA) and BV13 (AGGCCTAAAG-
GAACTAACTCCAC). The nomenclature used follows that of
Arden et al. [27]. PCR products were loaded on a 96-well ABI377
automated sequencer (Applied Biosystems, Foster City, CA) and
separated according to their nucleotide length, forming a profile of
peaks for each primer combination, spaced by 3 nucleotides as
expected for in-frame transcripts. Each peak corresponds to a
CDR3 length. The Immunoscope software [11] was used to obtain
peak area and nucleotide length and CDR3 profile displays from
sequencer raw data. As negative control for TCR recombination,
mRNA from spleen cells of b-enhancer KO mice [12] was
processed as the other samples and was found negative for the
expression of TCRb chains.
Sequencing analyses
For single peak Va and Vb profiles, direct sequencing was
performed with AV and AC, and BV and BC primers following
the recommendations of the BigDye Terminator v1.1 Cycle
Sequencing Ready Reaction kit (Applied Biosystems). PCR
products were then incubated with 0.5 U of shrimp alkaline
phosphatase and 5 U of exonuclease I (GE Healthcare) at 37uC
for 40 min, followed by 20 min at 80uC. DNA alignments were
performed using the GCG package (Genetics Computer Group,
Accelrys, Cambridge, U.K.). For multi-peak Va and Vb profiles,
AV-AC and BV-BC PCR products were cloned using the TOPO
TA cloning kit (Invitrogen) following the manufacturer’s instruc-
tions. Plasmid DNA from individual colonies was amplified with
the same primers and sequenced, as above.
Supporting Information
Figure S1 RAG-2-re-expression in OT-1 TCR Tg T cells.
Found at: doi:10.1371/journal.pone.0010238.s001 (0.14 MB TIF)
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